LabSpinner
LabSpinner, a brand of ExoDiscovery Technologies Inc., develops and sells the ExoDisc microfluidic cartridge and LabSpinner benchtop device for automated extracellular vesicle isolation, serving academic researchers, pharmaceutical and biotech firms, diagnostics labs, and veterinary clinics globally.
- Company typePrivate
- Founded2018
- HeadquartersYangji, South Korea
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What LabSpinner does
LabSpinner, operated under the legal entity ExoDiscovery Technologies Inc., is a biotechnology instrumentation company commercializing automated exosome (extracellular vesicle) isolation for research and pre-clinical sample preparation. Founded in 2018 and headquartered in Yangji, South Korea with California-governed corporate domicile, the company employs 11-50 people and operates as a privately held for-profit business. Its product system comprises two integrated components: the ExoDisc™ single-use microfluidic cartridge and a purpose-built LabSpinner benchtop device that together apply centrifugal microfluidic ("lab-on-a-disc") technology to drive biosamples through size-selective filtration channels, separating 30-200 nm EVs from larger particles, cell debris, and free proteins without pumps, valves, or external pressure. The platform reports ~95% EV recovery versus 5-25% with ultracentrifugation, sub-30-minute protocols versus 3-5 hours, and inter-assay CV below 5% versus 20-40% with conventional methods.
The underlying technology is anchored by an academic lineage — co-founder and CSO Dr. Yoon Cho is a Royal Society of Chemistry Fellow, National Academy of Engineering of Korea member, and UNIST professor; CTO Dr. David Lee previously led Lab-on-a-Chip FDA approval work at Samsung. Performance claims have been independently validated in peer-reviewed publications across ACS Nano (2017), Theranostics (2019), and ACS Applied Materials & Interfaces (2023), with the research output extending into additional journals including Analytical Chemistry, Lab Chip, JoVE, and IOVS. The LabSpinner trademark and ExoDisc™ trademark are both registered to ExoDiscovery Technologies Inc.
LabSpinner monetizes through a razor-and-blade revenue model combining one-time hardware sales of the benchtop device with recurring consumable revenue from single-use ExoDisc cartridges. Pricing is quote-based and not publicly disclosed; sales run through a direct website model with email ([email protected]) responding within 1-2 business days and no resellers or distributors apparent. The primary customer segments are academic research institutions conducting biomarker discovery and EV biology studies, pharmaceutical and biotechnology companies developing EV-based therapeutics and drug delivery systems, and diagnostics laboratories requiring standardized sample preparation; veterinary regenerative medicine is a secondary use case. Marketing relies on scientific publications as earned-media credibility rather than paid demand generation, and the product is labeled For Research Use Only with no diagnostic or therapeutic approvals to date.
LabSpinner firmographics
Firmographics- Name
- LabSpinner
- Legal name
- ExoDiscovery Technologies Inc.
- Website
- https://labspinner.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- LabSpinner, a brand of ExoDiscovery Technologies Inc., develops and sells the ExoDisc microfluidic cartridge and LabSpinner benchtop device for automated extracellular vesicle isolation, serving academic researchers, pharmaceutical and biotech firms, diagnostics labs, and veterinary clinics globally.
- Ownership category
- akta.pro rank
LabSpinner industry classification
Industry- Product category
- Exosome Isolation Instruments
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Laboratory Analytical Instruments (3826)
- akta.pro primary industry
- Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics) (HLAHAAAN)
- akta.pro secondary industries
- Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations) (HLAGAIAD), Liquid Biopsy Biomarkers (ctDNA/ctRNA/CTCs/exosomes) (HLAAAMAH)
Keywords
Where LabSpinner is headquartered
LocationHeadquarters
- HQ city
- Yangji
- HQ country
- South Korea
- HQ region
- Asia
Markets served
LabSpinner business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations
Revenue model
- LabSpinner Instrument Sales: Sale of LabSpinner benchtop device - purpose-built centrifuge for ExoDisc cartridges. One-time hardware purchase with no additional equipment needed.
- ExoDisc Consumable Cartridges: Single-use ExoDisc cartridges sold for each isolation run. 6 samples per disc, single-use to eliminate cross-contamination. Recurring consumable revenue tied to sample throughput.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
LabSpinner product offering
Product offeringCore offering
LabSpinner sells a two-part automated exosome isolation system: the ExoDisc™ single-use microfluidic cartridge (six sample channels, 1-4 mL input) and the LabSpinner benchtop centrifugal device. Together they use centrifugal microfluidics and size-selective filtration to isolate extracellular vesicles (30-200 nm) from plasma, serum, urine, and cell culture media in under 30 minutes with approximately 95% recovery and less than 5% inter-assay CV, replacing ultracentrifugation-based workflows for academic, pharmaceutical, diagnostics, and veterinary customers.
Product overview
LabSpinner by ExoDiscovery Technologies Inc. offers a unified product system for automated exosome isolation consisting of two integrated components: the ExoDisc™ single-use cartridge (a centrifugal microfluidic consumable) and the LabSpinner benchtop instrument (the compatible processing device). The system automates EV isolation from biosamples using centrifugal force-driven size-selective filtration, eliminating the need for ultracentrifuges, chromatography columns, or specialized training. The ExoDisc cartridge is loaded into the LabSpinner device, which spins the cartridge to drive samples through microfluidic channels that separate EVs (30-200 nm) from larger particles and free proteins. The result is purified EVs delivered in under 30 minutes with ~95% recovery and <5% inter-assay CV.
Differentiator
Problem solved
Functional benefit
Brands
- ExoDisc™: Automated exosome isolation device using centrifugal microfluidic technology for EV isolation from biosamples
Products and services
- ExoDisc™ Cartridge
Quantifiable outcome
- ~95% EV recovery rate vs 5-25% with ultracentrifugation
- +5 more outcomes
Companies that use LabSpinner
Customer profileSegments4 records
Ideal customer profiles4 records
LabSpinner technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
LabSpinner partnerships and signals
Strategic signalScale indicators3 records
Recent moves5 records
Expansion highlights5 records
LabSpinner competitors and assessment
Company assessmentDirect peers
- System Biosciences (SBI): SBI sells ExoQuick and other precipitation-based exosome isolation kits and reagents. Direct competitor to LabSpinner's ExoDisc in the EV isolation workflow with overlapping academic and pharma/biotech customers.
- Izon Science: Izon produces qEV size-exclusion columns and the Automated Fraction Collector for EV isolation. Targets the same academic and translational research customers seeking standardized, higher-throughput EV isolation than ultracentrifugation.
Broad incumbents
- Bio-Techne (ExoCap): Bio-Techne's ExoCap reagent line isolates EVs via proprietary precipitation/spin-column methods, going head-to-head with ExoDisc in biomarker discovery and EV research workflows at a much larger commercial scale.
- Miltenyi Biotec: Miltenyi offers magnetic bead-based EV isolation kits (e.g., MACS columns) and broader cell-separation instrumentation. A broad incumbent whose EV reagent line competes with ExoDisc in pharma and translational research labs.
- Thermo Fisher Scientific: Thermo Fisher sells Total Exosome Isolation reagents and dominates the ultracentrifuge market that ExoDisc benchmarks against. Its installed-base advantage and bundled workflows make it the dominant incumbent in EV sample prep.
- Beckman Coulter: Beckman Coulter is the leading supplier of ultracentrifuges — the gold-standard method ExoDisc is designed to replace. Its installed base of centrifuges, rotors, and trained users represents both a competitive moat and the displaced incumbent.
- QIAGEN: QIAGEN's exosome kits and nucleic-acid extraction workflows target the same downstream liquid-biopsy pipeline ExoDisc feeds. A broad incumbent that competes at the sample-prep-to-assay interface in pharma and diagnostics labs.
- Sartorius: Sartorius supplies bioprocess filtration, lab consumables, and tangential-flow filtration systems used in EV manufacturing and concentration. A broad incumbent in upstream/downstream bioprocessing whose filtration portfolio competes with microfluidic EV processing approaches.
Emerging players
- Cell Guidance Systems: Cell Guidance Systems sells Exo-spin and other EV isolation/purification products to academic and translational research labs. A smaller emerging player with overlapping customer profile to LabSpinner.
- NanoFCM: NanoFCM provides nanoflow cytometry instruments for EV characterization, complementing but partially overlapping with isolation workflows. An emerging player in the broader EV tools market that customers often buy alongside isolation products.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
LabSpinner social profiles
Digital presenceLabSpinner financial estimates
Financial estimateRevenue estimate
Valuation estimate
LabSpinner leadership team
Management profileNumber of profiles
Profiles4 records
LabSpinner funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
LabSpinner M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about LabSpinner
What does LabSpinner do?
LabSpinner sells a two-part automated exosome isolation system: the ExoDisc™ single-use microfluidic cartridge (six sample channels, 1-4 mL input) and the LabSpinner benchtop centrifugal device. Together they use centrifugal microfluidics and size-selective filtration to isolate extracellular vesicles (30-200 nm) from plasma, serum, urine, and cell culture media in under 30 minutes with approximately 95% recovery and less than 5% inter-assay CV, replacing ultracentrifugation-based workflows for academic, pharmaceutical, diagnostics, and veterinary customers.
Is LabSpinner a public or private company?
LabSpinner is a private company. It is classified as venture growth investor backed and is currently operating.
When was LabSpinner founded?
LabSpinner was founded in 2018. It employs 11 to 50 people.
Where is LabSpinner based?
LabSpinner is headquartered in Yangji, South Korea, in the Asia region.
How does LabSpinner make money?
Two revenue lines are on record. LabSpinner Instrument Sales are the primary driver. The others are exoDisc Consumable Cartridges.
Who are LabSpinner's main competitors?
Direct peers on record are System Biosciences (SBI) and Izon Science. Broad incumbents are Bio-Techne (ExoCap), Miltenyi Biotec, Thermo Fisher Scientific, Beckman Coulter, QIAGEN and Sartorius. Emerging players are Cell Guidance Systems and NanoFCM.
Does LabSpinner have an API?
No public API is recorded for LabSpinner.
What industry is LabSpinner in?
LabSpinner's product category is Exosome Isolation Instruments. Its primary akta.pro industry code is HLAHAAAN, Laboratory Automation, Sample Prep & Liquid Handling (IVD Lab Diagnostics), with a secondary code of HLAGAIAD, Liquid Handling & Laboratory Automation (Pipettes, Robots, Workstations). Its NAICS code is 334516 and its SIC code is 3826.